Catalyst Pharmaceuticals Inc (CPRX) concluded trading on Thursday at a closing price of $16.03, with 4.15 million shares of worth about $66.59 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.61% during that period and on Thursday the price saw a gain of about 10.10%. Currently the company’s common shares owned by public are about 105.26M shares, out of which, 91.12M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 31 times over the past 12 months. They bought 760,000 shares in 16 of the transactions. In 15 selling transactions, insiders dumped 300,093 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stock saw a price change of 15.32% in past 5 days and over the past one month there was a price change of 8.53%. Year-to-date (YTD), CPRX shares are showing a performance of -4.64% which increased to 5.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.09 but also hit the highest price of $18.22 during that period. The average intraday trading volume for Catalyst Pharmaceuticals Inc shares is 1.45 million. The stock is currently trading 15.88% above its 20-day simple moving average (SMA20), while that difference is up 8.85% for SMA50 and it goes to 18.71% higher than SMA200.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) currently have 105.26M outstanding shares and institutions hold larger chunk of about 71.03% of that.
The stock has a current market capitalization of $1.72B and its 3Y-monthly beta is at 0.90. PE ratio of stock for trailing 12 months is 30.40, while it has posted earnings per share of $0.53 in the same period. It has Quick Ratio of 3.17 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CPRX, volatility over the week remained 3.93% while standing at 3.33% over the month.
Analysts are in expectations that Catalyst Pharmaceuticals Inc (CPRX) stock would likely to be making an EPS of $0.26 in the current quarter, while forecast for next quarter EPS is $0.32 and it is $1.39 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.23 which is $0.32 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.22 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 73.81% while it is estimated to increase by 25.11% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on December 21, 2023 offering an Outperform rating for the stock and assigned a target price of $30 to it. Coverage by ROTH Capital stated Catalyst Pharmaceuticals Inc (CPRX) stock as a Neutral in their note to investors on August 24, 2022, suggesting a price target of $15.50 for the stock. Stock get an Overweight rating from Piper Jaffray on October 05, 2016.
